Literature DB >> 32409873

Epidemiological and genetic characteristics of porcine reproduction and respiratory syndrome virus 2 in mainland China, 2017-2018.

Sisi Xie1,2, Wan Liang1,2,3, Xueying Wang1,2, Hongjian Chen1,2, Jie Fan1,2, Wenbo Song1,2, Lin Hua1,2, Xibiao Tang1,2, Huanchun Chen1,2, Zhong Peng4,5, Bin Wu6,7.   

Abstract

Porcine reproductive and respiratory syndrome virus 2 (PRRSV2) is a major threat to the global pig industry, particularly in China, the world's largest pig-rearing and pork-production country. Continuously monitoring the epidemiological and genetic characteristics of PRRSV epidemic strains is beneficial for prevention and control of infection. Previously, we reported the epidemiological and genetic characteristics of PRRSV2 in China from 2012 to 2016. Here, the epidemiological and genetic characteristics of PRRSV2 in China from 2017 to 2018 are reported. During these two years, we collected different types of porcine samples from 2428 pig farms in 27 provinces in China. Of the 7980 samples collected, 2080 (26.07%) were positive for PRRSV2 ORF5 by RT-PCR. The positive rate of PRRSV detection between different regions of China ranged from 8.12% to 29.33%, and from 7.96% to 55.50% between different months. Phylogenetic analysis based on the ORF5 gene revealed that the PRRSV2 strains currently circulating in China belong to five clades, and most of the PRRSVs detected are highly pathogenic PRRSVs (HP-PRRSVs; clade IV) and PRRSV NADC30-like strains (clade I). Sequence analysis revealed multiple amino acid mutation types, including amino acid changes and deletions in both the GP5 and Nsp2 proteins. The presence of these mutations may have an effect on the evolution of the virus by altering the viral titer and/or affecting the antibody response against the virus.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32409873     DOI: 10.1007/s00705-020-04661-z

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  6 in total

1.  Development of recombinant nucleocapsid protein-based indirect enzyme-linked immunosorbent assay for sero-survey of porcine reproductive and respiratory syndrome.

Authors:  S Phani Kashyap; Jagadish Hiremath; S Vinutha; Sharanagouda S Patil; Kuralayanapalya P Suresh; Parimal Roy; Divakar Hemadri
Journal:  Vet World       Date:  2020-12-05

2.  Efficacy of the Synergy Between Live-Attenuated and Inactivated PRRSV Vaccines Against a NADC30-Like Strain of Porcine Reproductive and Respiratory Syndrome Virus in 4-Week Piglets.

Authors:  Chaosi Li; Zhicheng Liu; Kai Chen; Jie Qian; Yulong Hu; Shuhe Fang; Zhi Sun; Chunhong Zhang; Lv Huang; Jianfeng Zhang; Nian Huang
Journal:  Front Vet Sci       Date:  2022-02-02

3.  The United States Swine Pathogen Database: integrating veterinary diagnostic laboratory sequence data to monitor emerging pathogens of swine.

Authors:  Tavis K Anderson; Blake Inderski; Diego G Diel; Benjamin M Hause; Elizabeth G Porter; Travis Clement; Eric A Nelson; Jianfa Bai; Jane Christopher-Hennings; Phillip C Gauger; Jianqiang Zhang; Karen M Harmon; Rodger Main; Kelly M Lager; Kay S Faaberg
Journal:  Database (Oxford)       Date:  2021-12-15       Impact factor: 3.451

4.  Epidemiological and Genetic Characteristics of Porcine Reproductive and Respiratory Syndrome Virus in South China Between 2017 and 2021.

Authors:  Kui Fang; Shudan Liu; Xiangmin Li; Huanchun Chen; Ping Qian
Journal:  Front Vet Sci       Date:  2022-04-08

Review 5.  Recent advances in the study of NADC34-like porcine reproductive and respiratory syndrome virus in China.

Authors:  Hong-Zhe Zhao; Feng-Xue Wang; Xiao-Yu Han; Hao Guo; Chun-Yu Liu; Li-Na Hou; Ya-Xin Wang; Hui Zheng; Lu Wang; Yong-Jun Wen
Journal:  Front Microbiol       Date:  2022-07-22       Impact factor: 6.064

6.  On-site differential diagnostic detection of HP-PRRSV and C-PRRSV using EuNPs-mAb fluorescent probe-based immunoassay.

Authors:  Junjie Yan; Bin Peng; Hui Chen; Zhiyuan Jin; Dongni Cao; Qifang Song; Jianhua Ye; Hong Wang; Yong Tang
Journal:  Anal Bioanal Chem       Date:  2021-07-31       Impact factor: 4.142

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.